Achieve Life Sciences (ACHV) Restructuring Costs (2016)
Achieve Life Sciences' (ACHV) quarterly Restructuring Costs came in at -$431000.0 in Q3 2016, down 131.35% on a QoQ basis from $1.4 million in Q2 2016.
Achieve Life Sciences (ACHV) Restructuring Costs (2016) Analysis & Trends
Achieve Life Sciences (ACHV) has 1 years of Restructuring Costs data on file, last reported at -$431000.0 in Q3 2016.
- Quarterly Restructuring Costs changed N/A year-over-year to -$431000.0 in Q3 2016, while the trailing twelve-month figure through Dec 2016 was $1.4 million (changed N/A YoY) and the FY2016 annual result came in at $1.4 million, changed N/A from the prior year.
- Restructuring Costs fell to -$431000.0 in Q3 2016, from $1.4 million in the prior quarter.
- In the past five years, Restructuring Costs ranged from a high of $1.4 million in Q2 2016 to a low of -$431000.0 in Q3 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Achieve Life Sciences | 330.88 Mn | 330.88 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2016 | -431,000.00 |
| Jun 30, 2016 | 1.38 Mn |
| Mar 31, 2016 | 431,000.00 |